back to Australia directory
australia clinical guidance

Hepatitis C in primary care: screening, interpretation, and referral

A detailed Australian summary of hepatitis c in primary care: screening, interpretation, and referral, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Offer hepatitis C testing for current or previous injecting, incarceration, unsterile procedures, endemic-country exposure, transfusion-era risk or unexplained liver disease. Use antibody testing for exposure and HCV RNA for current infection, recognizing the window period and immunocompromise limitations. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian HCV recommendations

The Bottom Line

  • Offer hepatitis C testing for current or previous injecting, incarceration, unsterile procedures, endemic-country exposure, transfusion-era risk or unexplained liver disease.
  • Use antibody testing for exposure and HCV RNA for current infection, recognizing the window period and immunocompromise limitations.
  • A positive antibody with negative RNA indicates no current viraemia but does not create immunity against reinfection.
  • For detectable RNA, assess fibrosis, liver and kidney function, hepatitis B and HIV, medicines and pregnancy before antiviral selection.
sources for this section:Australian HCV recommendations

Practical clinical workflow

1

Topic-specific assessment action

Offer hepatitis C testing for current or previous injecting, incarceration, unsterile procedures, endemic-country exposure, transfusion-era risk or unexplained liver disease.
2

Topic-specific diagnostic action

For detectable RNA, assess fibrosis, liver and kidney function, hepatitis B and HIV, medicines and pregnancy before antiviral selection.
3

Topic-specific management action

Most uncomplicated adults can receive direct-acting antiviral treatment in primary care under Australian guidance with interaction and adherence checks.
4

Topic-specific follow-through

Use pan-genotypic therapy only after checking all prescribed, over-the-counter and complementary medicine interactions.
sources for this section:Australian HCV recommendations

Safety boundaries and escalation

  • Decompensated cirrhosis, hepatocellular carcinoma concern, complex renal disease, pregnancy or prior treatment failure needs specialist management.
  • Confirm cure with HCV RNA at the guideline interval and continue liver-cancer surveillance only when fibrosis stage requires it.
sources for this section:Australian HCV recommendations

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian HCV recommendations

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian HCV recommendations

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Gastroenterological Society of Australia and Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineAustralian recommendations for the management of hepatitis C virus infection: a consensus statementLiving web guideline checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.